Clinical Trial Update: RAPA-501 Therapy of ALS Expanded Access Protocol

View source ↗

Summary

This clinical trial update indicates that the expanded access protocol for RAPA-501 to treat amyotrophic lateral sclerosis is temporarily not available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• RAPA-501

Snippet

Sponsor: Rapa Therapeutics LLC | Conditions: Amyotrophic Lateral Sclerosis | Status: TEMPORARILY_NOT_AVAILABLE